A Pimarane Diterpene and Cytotoxic Angucyclines from a Marine-Derived Micromonospora sp. in Vietnam's East Sea

Marine Drugs

Volumn 13, Issue 9, 2015, Pages 5815-5827

  Mullowney, Michael W ^a   HAinmhire, Eoghainín Ó ^a   Tanouye, Urszula ^a   Burdette, Joanna E ^a   Van Pham, Cuong ^b   Murphy, Brian T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b GRADUATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

Author keywords

Actinomycete; Diterpene; Marine; Micromonospora; Ovarian cancer; Vietnam

Indexed keywords

ANGUCYCLINE DERIVATIVE; ANTIBIOTIC AGENT; DEHYDRORABELOMYCIN; DITERPENE; DOXORUBICIN; ISOPIMARA 2 ONE 3 OL 8,15 DIENE; LAGUMYCIN B; PHENANTHROVIRIDONE; PIMARANE; UNCLASSIFIED DRUG; WS 5995; ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT;

ACTINOBACTERIA; ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CANCER CELL LINE; CARBON NUCLEAR MAGNETIC RESONANCE; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA CLEAVAGE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; HIGH RESOLUTION MELTING ANALYSIS; IN VITRO STUDY; MASS SPECTROMETRY; MICROMONOSPORA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; OVARIAN CANCER CELL LINE; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; STREPTOMYCES LIVIDANS; ULTRAVIOLET SPECTROSCOPY; VIET NAM; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; FEMALE; HUMAN; METABOLISM; OVARIAN NEOPLASMS; SEA; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DITERPENES, ABIETANE; FEMALE; HUMANS; MICROMONOSPORA; MOLECULAR STRUCTURE; OCEANS AND SEAS; OVARIAN NEOPLASMS; VIETNAM;

EID: 84942871349     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13095815     Document Type: Article

References (29)

1. Fenical, W.; Jensen, P.R. Developing a new resource for drug discovery: Marine actinomycete bacteria. Nat. Chem. Biol. 2006, 2, 666-673.
2. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
3. Xie, P.; Ma, M.; Rateb, M.E.; Shaaban, K.A.; Yu, Z.; Huang, S.-X.; Zhao, L.-X.; Zhu, X.; Yan, Y.; Peterson, R.M.; et al. Biosynthetic potential-based strain prioritization for natural product discovery: A showcase for diterpenoid-producing actinomycetes. J. Nat. Prod. 2014, 77, 377-387.
4. Smanski, M.J.; Peterson, R.M.; Huang, S.-X.; Shen, B. Bacterial diterpene synthases: New opportunities for mechanistic enzymology and engineered biosynthesis. Curr. Opin. Chem. Biol. 2012, 16, 132-141.
5. Mullowney, M.W.; Hwang, C.H.; Newsome, A.G.; Wei, X.; Tanouye, U.; Wan, B.; Carlson, S.; Barranis, N.J.; Ó hAinmhire, E.; Chen, W.-L.; et al. Diaza-anthracene antibiotics from a freshwater-derived actinomycete with selective antibacterial activity toward Mycobacterium tuberculosis. ACS Infect. Dis. 2015, 1, 168-174.
6. Mullowney, M.W.; Ó hAinmhire, E.; Shaikh, A.; Wei, X.; Tanouye, U.; Santarsiero, B.D.; Burdette, J.E.; Murphy, B.T. Diazaquinomycins E-G, novel diaza-anthracene analogs from a marine-derived Streptomyces sp. Mar. Drugs 2014, 12, 3574-3586.
7. Balk-Bindseil, W.; Laatsch, H. Neue Naturstoffe aus dem Screening Mariner Actinomyceten: Isolierung und Strukturaufklä rung der Lagumycine und des Oceamycins. Ph.D. Thesis, University of Göttingen, Göttingen, Germany, 1995.
8. Yamashita, N.; Takashi, H.; Kazuo, S.; Haruo, S. 6-Hydroxytetrangulol, a new CPP32 protease inducer produced by Streptomyces sp. J. Antibiot. 1998, 1, 79-81.
9. Liu, W.C.; Parker, L.; Slusarchyk, S.; Greenwood, G.L.; Grahm, S.F.; Meyers, E. Isolation, characterization, and structure of rabelomycin, a new antibiotic. J. Antibiot. 1970, 23, 437-441.
10. Fendrich, G.; Zimmermann, W.; Gruner, J.; Auden, J.A.L. Phenanthridine Derivatives, Process for the Preparation Thereof, and Compositions Containing Them. U.S. Patent 5,093, 3 March 1990.
11. Gore, M.P.; Gould, S.J.; Weller, D.D. Synthesis of putative intermediates in the biosynthesis of the kinamycin antibiotics: Total synthesis of phenanthroviridin aglycon and related compounds. J. Org. Chem. 1992, 57, 2774-2783.
12. Ikushima, H.; Iguchi, E.; Kohsaka, M.; Aoki, H.; Imanaka, H. Streptomyces auranticolor sp. nov., a new anticoccidial antibiotics producer. J. Antibiot. 1980, 33, 1103-1106.
13. Ikushima, H.; Okamoto, M.; Tanaka, H.; Ohe, O.; Kohsaka, M.; Aoki, H.; Imanaka, H. New anticoccidial antibiotics, WS-5995 A and B: I. Isolation and characterization. J. Antibiot. 1980, 33, 1107-1113.
14. nd ed.; Oxford University Press: New York, NJ, USA, 2010; p. 48.
15. Moffitt, W.; Woodward, R.B.; Moscowitz, A.; Klyne, W.; Djerassi, C. Structure and the optical rotatory dispersion of saturated ketones. J. Am. Chem. Soc. 1961, 83, 4013-4018.
16. Dawson, B.A.; Girard, M.; Kindack, D.; Fillion, J.; Awang, D.V.C. 13C NMR of lapachol and some related naphthoquinones. Magn. Reson. Chem. 1989, 27, 1176-1177.
17. Yamashita, M.; Kaneko, M.; Tokuda, H.; Nishimura, K.; Kumeda, Y.; Iida, A. Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae. Bioorg. Med. Chem. 2009, 17, 6286-6291.
18. Domcke, S.; Sinha, R.; Levine, D.A.; Sander, C.; Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 2013, 4, 1-10.
19. LombÓ, F.; Abdelfattah, M.S.; Braña, A.F.; Salas, J.A.; Rohr, J.; Mé. Elucidation of oxygenation steps during oviedomycin biosynthesis and generation of derivatives with increased antitumor activity. ChemBioChem 2009, 10, 296-303.
20. Yamashita, N. Manufacture of Dehydrorabelomycin with Streptomyces Species and Use of the Antibiotic Agent as Antitumor Agent. JP 10201494 A, 4 August 1998.
21. Zhang, W.; Liu, Z.; Li, S.; Lu, Y.; Chen, Y.; Zhang, H.; Zhang, G.; Zhu, Y.; Zhang, G.; Zhang, W.; et al. Fluostatins I-K from the South China Sea-derived Micromonospora rosaria SCSIO N160. J. Nat. Prod. 2012, 75, 1937-1943.
22. Perchellet, E.M.; Sperfslage, B.J.; Qabaja, G.; Jones, G.B.; Perchellet, J.P. Quinone isomers of the WS-5995 antibiotics: Synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro. Anticancer Drugs 2001, 12, 401-417.
23. Kharel, M.K.; Pahari, P.; Shepherd, M.D.; Tibrewal, N.; Nybo, S.E.; Shaaban, K.A.; Rohr, J. Angucyclines: Biosynthesis, mode-of-action, new natural products, and synthesis. Nat. Prod. Rep. 2012, 29, 264-325.
24. Seaton, P.J.; Gould, S.J. Kinamycin biosynthesis. Derivation by excision of an acetate unit from a single-chain decaketide intermediate. J. Am. Chem. Soc. 1987, 109, 5282-5284.
25. Cone, M.C.; Hassan, A.M.; Gore, M.P.; Gould, S.J.; Borders, D.B.; Alluri, M.R. Detection of phenanthroviridin aglycon in a UV mutant of Streptomyces murayamaensis. J. Org. Chem. 1994, 59, 1923-1924.
26. Tibrewal, N.; Pahari, P.; Wang, G.; Kharel, M.K.; Morris, C.; Downey, T.; Hou, Y.; Bugni, T.S.; Rohr, J. Baeyer-Villiger C-C bond cleavage reaction in gilvocarcin and jadomycin biosynthesis. J. Am. Chem. Soc. 2012, 134, 18181-18184.
27. Cone, M.C.; Seaton, P.J.; Halley, K.A.; Gould, S.J. New products related to kinamycin from Streptomyces murayamaensis. I. Taxonomy, production, isolation, and biological properties. J. Antibiot. 1989, 42, 179-188.
28. Xie, Q.Y.; Qu, Z.; Lin, H.P.; Li, L.; Hong, K. Micromonospora haikouensis sp. nov., isolated from mangrove soil. Antonie Leeuwenhoek 2012, 101, 649-655.
29. Ó hAinmhire, E.; Quartuccio, S.M.; Cheng, W.; Ahmed, R.A.; King, S.M.; Burdette, J.E. Mutation or loss of p53 differentially modifies TGFinnodatabeta action in ovarian cancer. PLoS ONE 2014, 9, doi:10.1371/journal.pone.0089553.